GB9814316D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9814316D0
GB9814316D0 GBGB9814316.7A GB9814316A GB9814316D0 GB 9814316 D0 GB9814316 D0 GB 9814316D0 GB 9814316 A GB9814316 A GB 9814316A GB 9814316 D0 GB9814316 D0 GB 9814316D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9814316.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9814316.7A priority Critical patent/GB9814316D0/en
Publication of GB9814316D0 publication Critical patent/GB9814316D0/en
Priority to CH00723/99A priority patent/CH689805A8/en
Priority to AT0027999U priority patent/AT3185U3/en
Priority to GB9920332A priority patent/GB2339428A/en
Priority to AU36191/99A priority patent/AU3619199A/en
Priority to BR9911682-0A priority patent/BR9911682A/en
Priority to DE69911774T priority patent/DE69911774T2/en
Priority to DK99918159T priority patent/DK1089996T3/en
Priority to SI9930009T priority patent/SI1020464T1/en
Priority to JP2000558097A priority patent/JP2002519422A/en
Priority to ZA9902899A priority patent/ZA992899B/en
Priority to IE20000633A priority patent/IE20000633A1/en
Priority to NL1011874A priority patent/NL1011874C1/en
Priority to SI9930482T priority patent/SI1089996T1/en
Priority to PL99345214A priority patent/PL345214A1/en
Priority to IL14062899A priority patent/IL140628A/en
Priority to IE19990344A priority patent/IE990344A1/en
Priority to PT79901275T priority patent/PT1020464E/en
Priority to LU90388A priority patent/LU90388B1/en
Priority to NL1011875A priority patent/NL1011875C2/en
Priority to NZ509180A priority patent/NZ509180A/en
Priority to ES99303151T priority patent/ES2149044T3/en
Priority to SE9901462A priority patent/SE9901462A0/en
Priority to IT1999MI000866A priority patent/IT1312540B1/en
Priority to NO19991944A priority patent/NO319030B1/en
Priority to CA002269999A priority patent/CA2269999A1/en
Priority to FI990922A priority patent/FI112077B/en
Priority to IE19990343 priority patent/IES81166B2/en
Priority to AU23928/99A priority patent/AU732211C/en
Priority to PCT/GB1999/001253 priority patent/WO2000001694A1/en
Priority to GB0216752A priority patent/GB2377637A/en
Priority to GB0119695A priority patent/GB2367003A/en
Priority to SI9930002T priority patent/SI0970955T1/en
Priority to KR1020007015099A priority patent/KR20010053336A/en
Priority to EP99303151A priority patent/EP0970955B1/en
Priority to PT99918159T priority patent/PT1089996E/en
Priority to HU0102334A priority patent/HUP0102334A3/en
Priority to GB0026487A priority patent/GB2352395B/en
Priority to TR2001/00054T priority patent/TR200100054T2/en
Priority to DE29907248U priority patent/DE29907248U1/en
Priority to DE69900007T priority patent/DE69900007T2/en
Priority to AU23937/99A priority patent/AU713131B3/en
Priority to ES009900849A priority patent/ES2158778B1/en
Priority to EP00201289A priority patent/EP1020463A1/en
Priority to AU23938/99A priority patent/AU713877B3/en
Priority to DE19918588A priority patent/DE19918588A1/en
Priority to SK2026-2000A priority patent/SK20262000A3/en
Priority to CN99810281A priority patent/CN1127502C/en
Priority to BE9900293A priority patent/BE1012403A5/en
Priority to FI990190U priority patent/FI4209U1/en
Priority to US09/299,060 priority patent/US6063927A/en
Priority to DK199900176U priority patent/DK199900176U3/en
Priority to EP00201290A priority patent/EP1020464B1/en
Priority to GB9909505A priority patent/GB2336364B/en
Priority to ARP990101885A priority patent/AR011759A1/en
Priority to DK99303151T priority patent/DK0970955T3/en
Priority to GR990100140A priority patent/GR990100140A/en
Priority to FR9905185A priority patent/FR2780728B1/en
Priority to EP99918159A priority patent/EP1089996B1/en
Priority to PT99303151T priority patent/PT970955E/en
Priority to IE20000894A priority patent/IES20000894A2/en
Priority to DK199900554A priority patent/DK199900554A/en
Priority to BE9900294A priority patent/BE1011664A6/en
Priority to EP02078483A priority patent/EP1288214A1/en
Priority to AT99918159T priority patent/ATE251155T1/en
Priority to PT102291A priority patent/PT102291B/en
Priority to ES99918159T priority patent/ES2209428T3/en
Priority to IE20000893A priority patent/IES20000893A2/en
Priority to AT99303151T priority patent/ATE195121T1/en
Priority to ARP990101908A priority patent/AR018197A1/en
Priority to NL1012272A priority patent/NL1012272C1/en
Priority to NL1012271A priority patent/NL1012271C2/en
Priority to DK199900234U priority patent/DK199900234U4/en
Priority to BR9911679-0A priority patent/BR9911679A/en
Priority to HU0103712A priority patent/HUP0103712A3/en
Priority to TR2001/00055T priority patent/TR200100055T2/en
Priority to CA002336470A priority patent/CA2336470A1/en
Priority to IDW20010252A priority patent/ID27766A/en
Priority to EP99932772A priority patent/EP1091958A1/en
Priority to PCT/EP1999/004543 priority patent/WO2000001692A1/en
Priority to SK2024-2000A priority patent/SK20242000A3/en
Priority to KR1020007015100A priority patent/KR20010053337A/en
Priority to JP2000558095A priority patent/JP2002519421A/en
Priority to APAP/P/2000/002017A priority patent/AP2000002017A0/en
Priority to CZ20004923A priority patent/CZ20004923A3/en
Priority to IL14038599A priority patent/IL140385A0/en
Priority to AU49039/99A priority patent/AU4903999A/en
Priority to EA200100098A priority patent/EA200100098A1/en
Priority to PL99345365A priority patent/PL345365A1/en
Priority to CN99810197A priority patent/CN1314906A/en
Priority to BE9900832A priority patent/BE1012420A6/en
Priority to DK00201290T priority patent/DK1020464T3/en
Priority to DE60000003T priority patent/DE60000003T2/en
Priority to AT00201290T priority patent/ATE202777T1/en
Priority to ES00201290T priority patent/ES2157881T3/en
Priority to GR20000402015T priority patent/GR3034328T3/en
Priority to FR0014325A priority patent/FR2802098A1/en
Priority to NO20006547A priority patent/NO20006547L/en
Priority to DK200000390U priority patent/DK200000390U1/en
Priority to ZA200100020A priority patent/ZA200100020B/en
Priority to BG105204A priority patent/BG105204A/en
Priority to US09/803,798 priority patent/US20010023252A1/en
Priority to US09/805,812 priority patent/US20010023253A1/en
Priority to GR20010401061T priority patent/GR3036208T3/en
Priority to AU2002100370A priority patent/AU2002100370A4/en
Priority to US09/960,033 priority patent/US20020035130A1/en
Priority to HK01107165A priority patent/HK1037877A1/en
Priority to US10/174,380 priority patent/US20020193406A1/en
Priority to US10/430,026 priority patent/US20030203937A1/en
Priority to US10/828,660 priority patent/US20040247667A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB9814316.7A 1998-07-02 1998-07-02 Novel compounds Ceased GB9814316D0 (en)

Priority Applications (110)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
CH00723/99A CH689805A8 (en) 1998-07-02 1999-04-20 Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it.
AT0027999U AT3185U3 (en) 1998-07-02 1999-04-23 PAROXETINE METHANE SULPHONATE
GB9920332A GB2339428A (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
AU36191/99A AU3619199A (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
BR9911682-0A BR9911682A (en) 1998-07-02 1999-04-23 Paroxetine methane sulfonate
DE69911774T DE69911774T2 (en) 1998-07-02 1999-04-23 PAROXETINMETHANE SULFONATE ACETONITRILE SOLVATE 1: 1
DK99918159T DK1089996T3 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate-acetonitrile solvate 1: 1
SI9930009T SI1020464T1 (en) 1998-07-02 1999-04-23 Paroxetine methansulfonate
JP2000558097A JP2002519422A (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
ZA9902899A ZA992899B (en) 1998-07-02 1999-04-23 Novel compound.
IE20000633A IE20000633A1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
NL1011874A NL1011874C1 (en) 1998-07-02 1999-04-23 New connection.
SI9930482T SI1089996T1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate acetonitrile solvate 1:1
PL99345214A PL345214A1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
IL14062899A IL140628A (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate and pharmaceutical compositions comprising it
IE19990344A IE990344A1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
PT79901275T PT1020464E (en) 1998-07-02 1999-04-23 PAROXETINE METHOSULPHONATE
LU90388A LU90388B1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate, useful in treatment of depression, neuroses and anxiety
NL1011875A NL1011875C2 (en) 1998-07-02 1999-04-23 New connection.
NZ509180A NZ509180A (en) 1998-07-02 1999-04-23 Paroxetine Methanesulfonate
ES99303151T ES2149044T3 (en) 1998-07-02 1999-04-23 PAROXETINE METHANOSULFONATE.
SE9901462A SE9901462A0 (en) 1998-07-02 1999-04-23 Piperidine compounds, processes for their preparation, pharmaceutical compositions comprising them and their use in therapy
IT1999MI000866A IT1312540B1 (en) 1998-07-02 1999-04-23 COMPOSED.
NO19991944A NO319030B1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate, its use and method of preparation and pharmaceutical preparation.
CA002269999A CA2269999A1 (en) 1998-07-02 1999-04-23 Novel compound
FI990922A FI112077B (en) 1998-07-02 1999-04-23 A novel crystalline paroxetine methanesulfonate and a pharmaceutical composition containing it
IE19990343 IES81166B2 (en) 1998-07-02 1999-04-23 Novel compound
AU23928/99A AU732211C (en) 1998-07-02 1999-04-23 Novel compound
PCT/GB1999/001253 WO2000001694A1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
GB0216752A GB2377637A (en) 1998-07-02 1999-04-23 Paroxetine methanesulphonate composition
GB0119695A GB2367003A (en) 1998-07-02 1999-04-23 Paroxetine methansulphonate compositions
SI9930002T SI0970955T1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
KR1020007015099A KR20010053336A (en) 1998-07-02 1999-04-23 Paroxetine Methanesulfonate
EP99303151A EP0970955B1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
PT99918159T PT1089996E (en) 1998-07-02 1999-04-23 PAROXETINE METHOSULPHONATE
HU0102334A HUP0102334A3 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing the compound
GB0026487A GB2352395B (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
TR2001/00054T TR200100054T2 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
DE29907248U DE29907248U1 (en) 1998-07-02 1999-04-23 New connection
DE69900007T DE69900007T2 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
AU23937/99A AU713131B3 (en) 1998-07-02 1999-04-23 Novel compound
ES009900849A ES2158778B1 (en) 1998-07-02 1999-04-23 PAROXETINE SALT COMPOUNDS, THEIR PREPARATION AND USE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
EP00201289A EP1020463A1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
AU23938/99A AU713877B3 (en) 1998-07-02 1999-04-23 Novel compound
DE19918588A DE19918588A1 (en) 1998-07-02 1999-04-23 Piperidine compound
SK2026-2000A SK20262000A3 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
CN99810281A CN1127502C (en) 1998-07-02 1999-04-23 Salts of paroxetine
BE9900293A BE1012403A5 (en) 1998-07-02 1999-04-23 Salt paroxetine new method for its preparation and pharmaceutical composition containing same.
FI990190U FI4209U1 (en) 1998-07-02 1999-04-23 New compounds
US09/299,060 US6063927A (en) 1998-07-02 1999-04-23 Paroxetine derivatives
DK199900176U DK199900176U3 (en) 1998-07-02 1999-04-23 Paroxetine salts, pharmaceutical preparation containing these and uses thereof
EP00201290A EP1020464B1 (en) 1998-07-02 1999-04-23 Paroxetine methansulfonate
GB9909505A GB2336364B (en) 1998-07-02 1999-04-23 Paroxetine salt
ARP990101885A AR011759A1 (en) 1998-07-02 1999-04-23 COMPOUND DERIVED FROM PHENOXYMETHYLPIPERIDINE, PROCEDURES FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION, THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT, FOR THE PREPARATION OF AN INTERMEDIATE PRODUCT, A SOLVATE AND A CONTAINER
DK99303151T DK0970955T3 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
GR990100140A GR990100140A (en) 1998-07-02 1999-04-23 Novel compounds
FR9905185A FR2780728B1 (en) 1998-07-02 1999-04-23 NEW PAROXETINE SALT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
EP99918159A EP1089996B1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate acetonitrile solvate 1:1
PT99303151T PT970955E (en) 1998-07-02 1999-04-23 PAROXETINE METHOSULPHONATE
IE20000894A IES20000894A2 (en) 1998-07-02 1999-04-23 Paroxetine Methanesulfonate
DK199900554A DK199900554A (en) 1998-07-02 1999-04-23 Paroxetine salts, process for their preparation, pharmaceutical compositions comprising these and uses thereof
BE9900294A BE1011664A6 (en) 1998-07-02 1999-04-23 Salt paroxetine new method for its preparation and pharmaceutical composition containing same.
EP02078483A EP1288214A1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
AT99918159T ATE251155T1 (en) 1998-07-02 1999-04-23 PAROXETINE METHANESULFONATE-ACETONITRILE SOLVATE 1:1
PT102291A PT102291B (en) 1998-07-02 1999-04-23 PAROXETINE METHOSULPHONATE PROCESSES FOR THEIR PREPARATION PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND THEIR USE
ES99918159T ES2209428T3 (en) 1998-07-02 1999-04-23 A 1: 1 SOLVATE OF PPAROXETINE METHANOSULFONATE WITH ACETONITRILE.
IE20000893A IES20000893A2 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate
AT99303151T ATE195121T1 (en) 1998-07-02 1999-04-23 PAROXETINE METHANESULFONATE
ARP990101908A AR018197A1 (en) 1998-07-02 1999-04-26 PIPERIDINE COMPOUNDS, A PROCEDURE FOR THE PREPARATION, A COMPOSITION AND USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT
NL1012272A NL1012272C1 (en) 1998-07-02 1999-06-08 New connection.
NL1012271A NL1012271C2 (en) 1998-07-02 1999-06-08 New connection.
DK199900234U DK199900234U4 (en) 1998-07-02 1999-06-15 Paroxetine methanesulfonate in crystalline form, pharmaceutical composition containing it and use of the compound for
BR9911679-0A BR9911679A (en) 1998-07-02 1999-06-30 Paroxetine salts
HU0103712A HUP0103712A3 (en) 1998-07-02 1999-06-30 Salts of paroxetine, process for their preparation and their pharmaceutical use
TR2001/00055T TR200100055T2 (en) 1998-07-02 1999-06-30 Salts of paroxetine
CA002336470A CA2336470A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine
IDW20010252A ID27766A (en) 1998-07-02 1999-06-30 Paroxyseth Salts
EP99932772A EP1091958A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine
PCT/EP1999/004543 WO2000001692A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine
SK2024-2000A SK20242000A3 (en) 1998-07-02 1999-06-30 Salts of paroxetine
KR1020007015100A KR20010053337A (en) 1998-07-02 1999-06-30 Salts of Paroxetine
JP2000558095A JP2002519421A (en) 1998-07-02 1999-06-30 Paroxetine salt
APAP/P/2000/002017A AP2000002017A0 (en) 1998-07-02 1999-06-30 Salts of paroxetine.
CZ20004923A CZ20004923A3 (en) 1998-07-02 1999-06-30 Paroxetine salts
IL14038599A IL140385A0 (en) 1998-07-02 1999-06-30 Salts of paroxetine
AU49039/99A AU4903999A (en) 1998-07-02 1999-06-30 Salts of paroxetine
EA200100098A EA200100098A1 (en) 1998-07-02 1999-06-30 SALT PAROXETINE
PL99345365A PL345365A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine
CN99810197A CN1314906A (en) 1998-07-02 1999-06-30 Salts of paroxetine
BE9900832A BE1012420A6 (en) 1998-07-02 1999-12-23 Salt paroxetine new method for its preparation and pharmaceutical composition containing same.
DK00201290T DK1020464T3 (en) 1998-07-02 2000-04-10 Paroxetine methanesulfonate
DE60000003T DE60000003T2 (en) 1998-07-02 2000-04-10 paroxetine
AT00201290T ATE202777T1 (en) 1998-07-02 2000-04-10 PAROXETINE METHANESULFONATE
ES00201290T ES2157881T3 (en) 1998-07-02 2000-04-10 PAROXETINE METHANOSULFONATE.
GR20000402015T GR3034328T3 (en) 1998-07-02 2000-09-05 Paroxetine methanesulfonate
FR0014325A FR2802098A1 (en) 1998-07-02 2000-11-08 PHARMACEUTICAL COMPOSITIONS COMPRISING A SALT OF PAROXETINE
NO20006547A NO20006547L (en) 1998-07-02 2000-12-21 Salts of paroxetine
DK200000390U DK200000390U1 (en) 1998-07-02 2000-12-27 Pharmaceutical compositions for oral administration comprising paroxetine methanesulfonate.
ZA200100020A ZA200100020B (en) 1998-07-02 2001-01-02 Salts of paroxetine.
BG105204A BG105204A (en) 1998-07-02 2001-01-31 Salts of paroxetine
US09/803,798 US20010023252A1 (en) 1998-07-02 2001-03-12 Novel compound
US09/805,812 US20010023253A1 (en) 1998-07-02 2001-03-14 Novel compound
GR20010401061T GR3036208T3 (en) 1998-07-02 2001-07-11 Paroxetine methansulfonate
AU2002100370A AU2002100370A4 (en) 1998-07-02 2001-07-11 Novel compound
US09/960,033 US20020035130A1 (en) 1998-07-02 2001-09-21 Novel compound
HK01107165A HK1037877A1 (en) 1998-07-02 2001-10-11 Paroxetine methanesulfonate acetonitrile solvate 1:1
US10/174,380 US20020193406A1 (en) 1998-07-02 2002-06-18 Novel compound
US10/430,026 US20030203937A1 (en) 1998-07-02 2003-05-06 Novel compound
US10/828,660 US20040247667A1 (en) 1998-07-02 2004-04-21 Novel compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds

Publications (1)

Publication Number Publication Date
GB9814316D0 true GB9814316D0 (en) 1998-09-02

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9814316.7A Ceased GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds

Country Status (21)

Country Link
EP (1) EP1091958A1 (en)
JP (1) JP2002519421A (en)
KR (1) KR20010053337A (en)
CN (1) CN1314906A (en)
AP (1) AP2000002017A0 (en)
AU (2) AU4903999A (en)
BG (1) BG105204A (en)
BR (1) BR9911679A (en)
CA (1) CA2336470A1 (en)
CZ (1) CZ20004923A3 (en)
EA (1) EA200100098A1 (en)
GB (1) GB9814316D0 (en)
HU (1) HUP0103712A3 (en)
ID (1) ID27766A (en)
IL (1) IL140385A0 (en)
NO (1) NO20006547L (en)
PL (1) PL345365A1 (en)
SK (1) SK20242000A3 (en)
TR (1) TR200100055T2 (en)
WO (1) WO2000001692A1 (en)
ZA (2) ZA992899B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1622630T3 (en) 2003-05-07 2013-01-31 Osteologix As Strontium combinations for the prophylaxis/treatment of cartilage and/or bone conditions
DK1534305T3 (en) 2003-05-07 2007-02-05 Osteologix As Treatment of cartilage / bone disorders with water-soluble strontium salts
US20080167513A1 (en) 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
CA2565840A1 (en) 2004-05-06 2005-11-17 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
KR100672184B1 (en) * 2004-09-21 2007-01-19 주식회사종근당 Choline or Choline Derivative Salts of Paroxetine
CA2672267C (en) 2006-07-27 2016-05-31 Emisphere Technologies, Inc. Arylsulfanyl compounds and compositions for delivering active agents
CN109212055B (en) * 2018-08-19 2021-05-07 丁立平 Gas chromatography-mass spectrometry combined method for determining four trace monohalogenated phenylacetic acids in drinking water
CN109342633B (en) * 2018-11-27 2020-10-02 北京市化工职业病防治院 Method for detecting metabolites of benzene, toluene and xylene in urine
CN111337460B (en) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 High-stability Halo-tag probe and synthesis and biological application thereof
US12172966B1 (en) 2023-09-15 2024-12-24 King Faisal University 2-(1H-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
DE3688827T2 (en) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidine derivative, its manufacture and its use as a medicine.
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (en) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them
ATE200781T1 (en) * 1997-06-10 2001-05-15 Synthon Bv 4-PHENYLPIPERIDINE DERIVATIVES
KR20010040711A (en) * 1998-02-06 2001-05-15 피터 기딩스 Salts of Paroxetine

Also Published As

Publication number Publication date
EA200100098A1 (en) 2001-08-27
IL140385A0 (en) 2002-02-10
BR9911679A (en) 2002-01-29
SK20242000A3 (en) 2001-07-10
NO20006547L (en) 2001-02-12
AP2000002017A0 (en) 2000-12-31
CA2336470A1 (en) 2000-01-13
PL345365A1 (en) 2001-12-17
WO2000001692A1 (en) 2000-01-13
HUP0103712A2 (en) 2002-05-29
ZA992899B (en) 2000-03-29
CZ20004923A3 (en) 2001-08-15
KR20010053337A (en) 2001-06-25
AU4903999A (en) 2000-01-24
EP1091958A1 (en) 2001-04-18
TR200100055T2 (en) 2001-07-23
ID27766A (en) 2001-04-26
BG105204A (en) 2001-11-30
NO20006547D0 (en) 2000-12-21
CN1314906A (en) 2001-09-26
ZA200100020B (en) 2002-03-25
HUP0103712A3 (en) 2002-09-30
AU2002100370A4 (en) 2002-06-06
JP2002519421A (en) 2002-07-02

Similar Documents

Publication Publication Date Title
GB9803411D0 (en) Novel compounds
GB9801392D0 (en) Novel compounds
GB9803751D0 (en) Novel compounds
GB9803287D0 (en) Novel compounds
GB9803290D0 (en) Novel compounds
GB9800337D0 (en) Novel compounds
GB9801630D0 (en) Novel compounds
GB9801635D0 (en) Novel compounds
GB9801643D0 (en) Novel compounds
GB9802533D0 (en) Novel compounds
GB9802638D0 (en) Novel compounds
GB9802639D0 (en) Novel compounds
GB9802640D0 (en) Novel compounds
GB9802645D0 (en) Novel compounds
GB9802646D0 (en) Novel compounds
GB9802653D0 (en) Novel compounds
GB9802655D0 (en) Novel compounds
GB9802656D0 (en) Novel compounds
GB9802657D0 (en) Novel compounds
GB9802658D0 (en) Novel compounds
GB9802659D0 (en) Novel compounds
GB9802661D0 (en) Novel compounds
GB9802664D0 (en) Novel compounds
GB9802665D0 (en) Novel compounds
GB9802698D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)